CRLF2 and acute lymphoblastic leukemia: About 50% of these Ph-like ALL patients harbored cytokine receptor-like factor 2 (CRLF2) rearrangements activating the PI3K/mTOR and Janus kinase (JAK)-STAT pathways, most notably among Hispanic patients [14].